Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

Viewpoints_Rich Colvin
PharmaShots Interview: bluebird bio’s Rich Colvin Shares Insights on the Skysona to Treat Early Cerebral Adrenoleukodystrophy
In an interview with PharmaShots, Rich Colvin, M.D., Ph.D., Interim Chief Medical Officer at bluebird bio shares his views on the Skysona and its working on CALD patients. Shots: If granted marketing authorization, Skysona would be the first approved one-time gene therapy for CALD which is a rare neurogenerative disease with typically childhood onset The CHMP opinion…
June 4, 2021
Viewpoints_Ken Keller
PharmaShots Interview: Daiichi Sankyo’s Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast Cancer
In an interview with PharmaShots, Ken Keller, President and Chief Executive Officer at Daiichi Sankyo and Global Head of the Daiichi Sankyo Oncology Business shared his views on the NICE CDF recommendation for Enhertu in unresectable or metastatic HER2 positive breast cancer and the company's growth and pipeline. Shots: The recommendation from NICE is based on the…
June 2, 2021
Viewpoints_Neil Solomons
PharmaShots Interview: Aurinia’s Neil Solomons Shares Insights on the Lupkynis
In an interview with PharmaShots, Neil Solomons, Co-founder and Chief Medical Officer of Aurinia shared his views on the data of Lupkynis (voclosporin) presented at the National Kidney Foundation 2021 Spring Clinical Meetings. Shots: New data analysis from the AURORA and AURA clinical studies shows that Aurinia's therapy demonstrated efficacy across all LN biopsy classes. These data show that treatment…
June 1, 2021
Viewpoints_Neil Moat
PharmaShots Interview: Abbott’s Neil Moat Shares Insights on the Next Generation TriClip Transcatheter Tricuspid Valve Repair System
In an interview with PharmaShots, Neil Moat, M.D., Chief Medical Officer of Abbott's Structural Heart Business shares his views on the CE mark approval of first-of-its-kind TriClip device. Shots: The new iteration of the device, called TriClip G4, offers new clip sizes and an enhanced leaflet grasping feature for physicians to further customize treatment to the complex tricuspid valve…
May 31, 2021
Viewpoints_Anthony Costello
PharmaShots Interview: Medidata’s Anthony Costello Shares Insights on the Transformative Sensor Cloud Platform for Connected Devices and Wearable Sensors in Clinical Trials
In an interview with PharmaShots, Anthony Costello, President, Patient Cloud at Medidata share his views on the launch of Sensor Cloud which is a transformative platform for managing a sensor and digital health technology data during the clinical trials. Shots: The company launches Sensor Cloud for managing sensor and digital health technology data during the clinical trial.…
May 25, 2021
Viewpoints_Dr. Allitia DiBernardo
PharmaShots Interview: Janssen’s Dr. Allitia DiBernardo Shares Insights on the Availability of Ponvory in the US
In an interview with PharmaShots, Dr. Allitia DiBernardo, Global Head of Medical Affairs for Neurology at the Janssen share her views on the availability of Ponvory in the US for MS patients. Shots: Ponvory offers patients superior efficacy in reducing annualized relapses and brain lesions over established oral therapy teriflunomide (Aubagio), with a safe and generally well-tolerated profile…
May 24, 2021
Viewpoints_Dipal Doshi
PharmaShots Interview: Entrada’s Dipal Doshi Shares Insights on the Series B Funding Utilize to Advance DMD Program into the Clinic
In an interview with PharmaShots, Dipal Doshi, President and Chief Executive Officer of Entrada Therapeutics share his views on $116M Series B financing and what does this milestone means for the company's pipeline. Shots: The Series B financing was led by Wellington Management Company, who was joined by Redmile Group, TCG Crossover, Greenspring Associates, Point72, Qatar Investment…
May 19, 2021
Viewpoints_Andrew Spiegel
PharmaShots Interview: GCCA’s Andrew Spiegel Shares Insights on the Clear Your View Campaign
In an interview with PharmaShots, Andrew Spiegel, Executive Director of the Global Colon Cancer Association shares the details of the campaign and put colors on the impact of complete biomarker testing for advanced CRC patients. Shots: The Clear Your View campaign is an awareness initiative sponsored by Guardant Health to raise awareness of the importance of complete biomarker testing…
May 18, 2021
Viewpoints_Sneha Nair and Claire Crossett
PharmaShots Interview: Women First Digital’s Sneha Nair and Claire Crossett Share Insights on the Launch of World’s First Abortion Virtual Assistant, Ally on WhatsApp
In an interview with PharmaShots, Sneha Nair, Global Communications Officer and Claire Crossett, Assistant Director at Women First Digital share insight on the launch of the world's first-ever abortion virtual assistant, Ally, on WhatsApp in celebration of World Health Day's 2021 theme: Building a fairer, healthier world. Shots: Ally, the HowToUse chatbot, is equipped to answer all medical abortion-related…
May 17, 2021
Load more